Avadel Pharmaceuticals Plc ADR (AVDL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Sales | 59,215 | 103,269 | 173,245 | 150,246 | 173,009 |
| Cost of Goods | 12,125 | 17,516 | 16,301 | 13,248 | 11,410 |
| Gross Profit | 47,090 | 85,753 | 156,944 | 136,998 | 161,599 |
| Operating Expenses | 71,327 | 191,195 | 67,740 | 142,211 | 91,251 |
| Operating Income | -24,112 | -104,926 | 89,505 | -4,965 | 70,758 |
| Interest Expense | 12,483 | 10,622 | 1,052 | 963 | 4,883 |
| Other Income | -1,987 | 2,351 | 4,207 | -3,790 | 11,830 |
| Pre-tax Income | -38,582 | -113,197 | 92,660 | -9,718 | 77,705 |
| Income Tax | -5,356 | -17,893 | 24,389 | 31,558 | 35,907 |
| Net Income Continuous | -33,226 | -95,304 | 68,271 | -41,276 | 41,798 |
| Net Income | $-33,226 | $-95,304 | $68,271 | $-41,276 | $41,798 |
| EPS Basic Total Ops | -0.89 | -2.55 | 1.69 | -1.00 | 1.03 |
| EPS Basic Continuous Ops | -0.89 | -2.55 | 1.69 | -1.00 | 1.03 |
| EPS Diluted Total Ops | -0.89 | -2.55 | 1.63 | -1.00 | 0.96 |
| EPS Diluted Continuous Ops | -0.89 | -2.55 | 1.63 | -1.00 | 0.96 |
| EPS Diluted Before Non-Recurring Items | -0.89 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-21,626 | $-94,673 | $95,120 | $9,524 | $83,890 |